Treatments for chronic myeloid leukemia: a qualitative systematic review
Roxanne Ferdinand,1 Stephen A Mitchell,2 Sarah Batson,2 Indra Tumur11Pfizer, Tadworth, UK; 2Abacus International, Bicester, UKBackground: Chronic myeloid leukemia (CML) is a myeloproliferative disorder of blood stem cells. The tyrosine kinase inhibitor (TKI) imatinib was the first targeted therapy l...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-08-01
|
| Series: | Journal of Blood Medicine |
| Online Access: | http://www.dovepress.com/treatments-for-chronic-myeloid-leukemia-a-qualitative-systematic-revie-a10614 |